Go to deals
Private Equity | Consumer & Retail

WD Lab Grown Diamonds has received an equity investment from Huron Capital Partners, LLC

WD Lab Grown Diamonds (WD) has received an equity investment from Huron Capital Partners LLC.

Founded in 2008, WD is a disruptive, rapidly growing producer of large, ultra-high-quality laboratory-grown diamonds for the jewelry, scientific and industrial markets. WD leverages patented and proprietary processes to grow diamonds with the same optical, chemical and physical properties as mined diamonds. The company’s exclusive technology and manufacturing capabilities place WD at the forefront of one of the fastest growing segments of the diamond industry. The company also offers new technologies and applications for diamonds in various other fields, including high pressure environments and medical and scientific uses. It partners with diamond retailers, wholesalers and manufacturers.

Huron Capital, a Detroit-based private equity firm with over US$1.8 billion of capital under management, expects to strategically accelerate WD’s future growth and further entrench its position as the world’s preeminent producer of gem-quality laboratory-grown diamonds.

This transaction provides resources and balance sheet flexibility to further accelerate WD’s impressive growth trajectory as well as a strategic partner for the company’s founding shareholders, who remain in day-to-day operational control.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to WD Lab Grown Diamonds in this transaction.

Service
M&A sell-side
Parties

Talk to the deal team

 James S. Grien

James S. Grien

Managing Director

Atlanta, United States
Oaklins TM Capital
 Jarrad  Zalkin

Jarrad Zalkin

Managing Director

Boston, United States
Oaklins TM Capital
 John  Dean

John Dean

Associate Director

Atlanta, United States
Oaklins TM Capital

Related deals

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Learn more
Commercial Tube Processing has been acquired by Nelson Global Products
Private Equity | Industrial Machinery & Components

Commercial Tube Processing has been acquired by Nelson Global Products

Tube Processing Corporation has sold its division Commercial Tube Processing (CTP) to Nelson Global Products Inc.

Learn more
Hardford has sold its wholly owned subsidiary Hardford Brands to Pharmaxim
Consumer & Retail

Hardford has sold its wholly owned subsidiary Hardford Brands to Pharmaxim

Hardford Holding AB has sold Hardford Brands AB to Pharmaxim AB.

Learn more